22.79
price up icon4.21%   0.92
pre-market  プレマーケット:  23.20   0.41   +1.80%
loading
前日終値:
$21.87
開ける:
$21.96
24時間の取引高:
173.75K
Relative Volume:
0.36
時価総額:
$1.25B
収益:
-
当期純損益:
$-102.09M
株価収益率:
-21.70
EPS:
-1.05
ネットキャッシュフロー:
$-108.72M
1週間 パフォーマンス:
+2.52%
1か月 パフォーマンス:
-2.65%
6か月 パフォーマンス:
+147.18%
1年 パフォーマンス:
+430.00%
1日の値動き範囲:
Value
$21.52
$22.80
1週間の範囲:
Value
$20.49
$23.47
52週間の値動き範囲:
Value
$3.91
$26.18

Dbv Technologies Adr Stock (DBVT) Company Profile

Name
名前
Dbv Technologies Adr
Name
セクター
Healthcare (1106)
Name
電話
33(0)155427878
Name
住所
107 AVENUE DE LA REPUBLIQUE, CHATILLON
Name
職員
117
Name
次回の収益日
2024-07-29
Name
最新のSEC提出書
Name
DBVT's Discussions on Twitter

Compare DBVT vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
DBVT
Dbv Technologies Adr
22.79 1.20B 0 -102.09M -108.72M -1.05
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.89 120.48B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
787.50 81.05B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
749.56 46.33B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
327.30 42.26B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.02 32.87B 5.36B 287.73M 924.18M 2.5229

Dbv Technologies Adr Stock (DBVT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-12-15 開始されました Cantor Fitzgerald Overweight
2025-12-03 開始されました Guggenheim Buy
2025-05-29 再開されました Goldman Sell
2023-01-04 アップグレード Societe Generale Hold → Buy
2022-12-16 ダウングレード Goldman Neutral → Sell
2022-05-10 ダウングレード Goldman Buy → Neutral
2021-09-14 アップグレード Societe Generale Hold → Buy
2021-01-22 ダウングレード Societe Generale Hold → Sell
2020-11-02 アップグレード Societe Generale Sell → Hold
2020-08-06 ダウングレード Societe Generale Buy → Sell
2020-08-05 繰り返されました H.C. Wainwright Buy
2020-03-17 ダウングレード Stifel Buy → Hold
2020-01-09 アップグレード Stifel Hold → Buy
2019-12-16 開始されました Citigroup Buy
2019-09-05 再開されました Morgan Stanley Equal-Weight
2019-06-17 開始されました Goldman Buy
2018-12-20 ダウングレード Barclays Overweight → Equal Weight
2018-12-20 ダウングレード BofA/Merrill Buy → Underperform
2018-12-20 ダウングレード Jefferies Buy → Hold
2018-12-20 ダウングレード Stifel Buy → Hold
2017-10-31 アップグレード Societe Generale Sell → Hold
2017-10-24 ダウングレード Societe Generale Buy → Sell
2017-10-23 ダウングレード Morgan Stanley Overweight → Equal-Weight
2017-06-23 開始されました Deutsche Bank Buy
2017-03-16 アップグレード Societe Generale Hold → Buy
2016-09-26 開始されました JMP Securities Mkt Outperform
2015-12-03 開始されました Barclays Overweight
2015-10-23 開始されました BofA/Merrill Buy
すべてを表示

Dbv Technologies Adr (DBVT) 最新ニュース

pulisher
Mar 04, 2026

DBV Technologies to Participate in Upcoming March Investor Conferences - markets.businessinsider.com

Mar 04, 2026
pulisher
Mar 04, 2026

Biotech DBV Technologies lines up back-to-back March investor events - Stock Titan

Mar 04, 2026
pulisher
Mar 03, 2026

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026 - ChartMill

Mar 03, 2026
pulisher
Mar 02, 2026

DBV Technologies stock surges on new peanut patch trial data - Investing.com

Mar 02, 2026
pulisher
Mar 02, 2026

Phase 3 VITESSE data highlighted by DBV Technologies (NASDAQ: DBVT) - Stock Titan

Mar 02, 2026
pulisher
Feb 28, 2026

DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting - The Manila Times

Feb 28, 2026
pulisher
Feb 28, 2026

DBV Technologies Highlights Additional Data from Successful - GlobeNewswire

Feb 28, 2026
pulisher
Feb 26, 2026

DBV Technologies (DBVT) Projected to Post Earnings on Thursday - Defense World

Feb 26, 2026
pulisher
Feb 25, 2026

Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA) and Palvella Therapeutics (PVLA) - The Globe and Mail

Feb 25, 2026
pulisher
Feb 24, 2026

DBV Technologies launches $150M ATM offering - MSN

Feb 24, 2026
pulisher
Feb 17, 2026

BioImpact LLC reports 9.99% DBV Technologies (DBVT) stake via shares and warrants - Stock Titan

Feb 17, 2026
pulisher
Feb 16, 2026

European Equities Traded in the US as American Depositary Receipts Lower Wednesday - MSN

Feb 16, 2026
pulisher
Feb 16, 2026

DBV Technologies to Participate in Biotech Summit - Intellectia AI

Feb 16, 2026
pulisher
Feb 16, 2026

DBV Technologies to Present VIASKIN® Data at AAAAI 2026 - Intellectia AI

Feb 16, 2026
pulisher
Feb 10, 2026

DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting - The Manila Times

Feb 10, 2026
pulisher
Feb 10, 2026

DBV Technologies S.A. - Via Ritzau

Feb 10, 2026
pulisher
Feb 09, 2026

DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit - markets.businessinsider.com

Feb 09, 2026
pulisher
Feb 09, 2026

Biotech summit to feature DBV Technologies CEO fireside chat - Stock Titan

Feb 09, 2026
pulisher
Feb 08, 2026

DBV Technologies (NASDAQ:DBVT) Upgraded at Wall Street Zen - Defense World

Feb 08, 2026
pulisher
Feb 07, 2026

DBV Technologies S.A. (NASDAQ:DBVT) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World

Feb 07, 2026
pulisher
Feb 04, 2026

European ADRs Slip As Winners And Losers Split By Region - Finimize

Feb 04, 2026
pulisher
Feb 04, 2026

European ADRs Inched Higher As GSK And Telefonica Jumped - Finimize

Feb 04, 2026
pulisher
Feb 03, 2026

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Galecto (GLTO), Roche Holding AG (OtherRHHVF) and Amgen (AMGN) - The Globe and Mail

Feb 03, 2026
pulisher
Jan 31, 2026

DBV Technologies (NASDAQ:DBVT) Stock Price Passes Above 50 Day Moving Average – What’s Next? - Defense World

Jan 31, 2026
pulisher
Jan 26, 2026

European ADRs Started The Week Higher In US Trading - Finimize

Jan 26, 2026
pulisher
Jan 19, 2026

DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing - Sahm

Jan 19, 2026
pulisher
Jan 18, 2026

DBV Technologies (NASDAQ:DBVT) Shares Gap Up – Still a Buy? - Defense World

Jan 18, 2026
pulisher
Jan 16, 2026

European ADRs Slipped, But Biotech Names Still Stole The Show - Finimize

Jan 16, 2026
pulisher
Jan 16, 2026

DBV Technologies Announces €166.7 Million in Gross Proceeds - GlobeNewswire

Jan 16, 2026
pulisher
Jan 16, 2026

DBV Technologies annonce avoir reçu un produit brut de 166,7 millions d'euros suite à l'exercice intégral des Bons de Souscription (BS) issus des ABSAs et des BS issus des PFW-BS-PFW émis dans le cadre de son financement de mars 2025 - GlobeNewswire Inc.

Jan 16, 2026
pulisher
Jan 16, 2026

Worthington Steel, Immunitybio, Riot Platforms, Micron Technology And Other Big Stocks Moving Higher On Friday - Benzinga

Jan 16, 2026
pulisher
Jan 15, 2026

DBV Technologies stock rating reiterated at Overweight by Cantor Fitzgerald - Investing.com

Jan 15, 2026
pulisher
Jan 13, 2026

DBV Technologies S.A. (NASDAQ:DBVT) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World

Jan 13, 2026
pulisher
Jan 10, 2026

European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading - MSN

Jan 10, 2026
pulisher
Jan 09, 2026

Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Abivax SA Sponsored ADR (ABVX) - The Globe and Mail

Jan 09, 2026
pulisher
Jan 08, 2026

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF - The Manila Times

Jan 08, 2026
pulisher
Jan 03, 2026

European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading - MSN

Jan 03, 2026
pulisher
Dec 31, 2025

How M&A Unlocked A Biotech Rebound In 2025— And What Comes Next? - Sahm

Dec 31, 2025
pulisher
Dec 28, 2025

The Insider Report: A Tape Fitting for the Holiday - Sahm

Dec 28, 2025

Dbv Technologies Adr (DBVT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Dbv Technologies Adr (DBVT) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
EPIC Bpifrance
Member of 10% owner group
Dec 17 '25
Sale
4.85
2,076,990
10,070,232
8,595,472
EPIC Bpifrance
Member of 10% owner group
Dec 18 '25
Sale
4.19
1,292,103
5,413,912
7,303,369
Mohideen Pharis
Chief Medical Officer
Nov 20 '25
Sale
2.88
6,496
18,708
103,153
Mohideen Pharis
Chief Medical Officer
Nov 21 '25
Sale
2.77
1,624
4,498
101,529
Mohideen Pharis
Chief Medical Officer
Jul 29 '25
Sale
2.22
464
1,030
109,649
Mohideen Pharis
Chief Medical Officer
May 22 '25
Sale
1.84
397
730
110,113
$47.43
price down icon 0.11%
$29.52
price up icon 6.00%
$57.80
price up icon 15.99%
$103.80
price up icon 3.02%
$149.88
price up icon 1.96%
biotechnology ONC
$299.02
price up icon 0.67%
大文字化:     |  ボリューム (24 時間):